Marquette Asset Management’s Medifast MED Stock Holding History

Marquette Asset Management’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$319K	Buy	+30,038	New	+$346K	0.04%	68

Other funds holding MED

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SCP

Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Marquette Asset Management's MED Position: Q2 2026 in Review

Marquette Asset Management opened a new position in Medifast (MED) in Q2 2026: 30,038 shares worth $319K. The stake represents 0.04% of the portfolio and ranks #68 among its holdings.

113 funds tracked by Wall St. Rank hold MED as of Q2 2026.

Marquette Asset Management held 30,038 shares of Medifast worth $319K as of Q2 2026.
Medifast was a new Marquette Asset Management position in Q2 2026.
Medifast made up 0.04% of Marquette Asset Management's portfolio in Q2 2026, its #68 holding.
113 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on Marquette Asset Management's 13F filing for Q2 2026, filed 9 Jul 2026.